Cheaper cancer care therapy earns big bucks for pharma company
ImmunoACT, in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 crore.
Founded by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in 2018.
ImmunoACT's NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October 2023. NexCAR19 was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in India.
In CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are exhausted.Each CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks up.Meanwhile, ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic advisor.Rahul Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion."
Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla, Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts. Globally, CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
16 minutes ago
- Business Standard
Union Bank of India puts 10 Future Group brands on block to recover dues
Public sector lender Union Bank of India has put on the block 10 brands of Future Brands Ltd, part of Kishore Biyani's Future Group, for recovery of dues. Brands being auctioned include BARE, HAUTE N SPICY, and STUDIO NYX, with the reserve price set at Rs 230 crore. The auction of secured assets is slated for the middle of August. The dues cover secured debt estimated at over Rs 181 crore, plus interest, costs, and other charges, according to the auction notice. The auction is being conducted under the Securitisation and Reconstruction of Financial Assets and Enforcement of Security Interest Act (SARFAESI), which enables banks and financial institutions to recover non-performing assets (NPAs). A senior bank executive said the lender has an exclusive first charge on the brands. The bank wants to explore the value of these brands, which are intangible assets. The account became an NPA in early 2022, and provisions have been made in line with regulatory norms. Future Brands, a Mumbai-based entity incorporated in 2006, is a brand and intellectual property rights company focused on creating, developing, managing, nurturing, and acquiring brands. In June 2024, Acuite downgraded Future Brands Ltd's long-term rating from 'B+' to 'D'. The downgrade was based on banker feedback indicating the account's categorisation as an NPA. The rating continues to be flagged as 'Issuer Not-Cooperating' and is based on the best available information. Highlighting weaknesses associated with the entity, the rating agency noted that servicing obligations were dependent on timely refinancing or infusion of funds by the promoters, and pointed to a moderate financial risk profile. Besides licensing, FBL has advised global and Indian companies such as Colgate-Palmolive, Eicher Motors, and Tata Motors on conceptual and operational brand challenges, offering insights and knowledge-based brand solutions. In 2020, FBL held the licences to 40 brands, including John Miller, BARE, DJ&C, Fresh & Pure, Lombard, Srishti, IQIP, Knighthood, KORYO, and Rig, across fashion, electronics, and FMCG formats.
&w=3840&q=100)
First Post
16 minutes ago
- First Post
Did EU get a raw deal in Trump trade pact? 7 facts
While the agreement may have averted a full-blown trade war and restored some predictability, many analysts argue the EU signed away too much: steep tariffs, massive purchases and little leverage in return. Whether this fiscal toll brings long-term value or leaves Brussels as a weaker negotiator remains under scrutiny. read more The sweeping trade agreement unveiled Sunday between the United States and European Union, forged under intense pressure from President Donald Trump, has sent shockwaves through European capitals, with many questionings whether the deal leaves the EU at a stark disadvantage. Here are seven crucial facts illustrating the challenges and concessions embedded in the pact: US imposes across-the-board 15% tariff on EU exports The agreement sets a 15% baseline tariff on nearly all EU goods entering the US, a sharp escalation from the previous average US tariff of about 1.6% on a trade-weighted basis for EU products. Core EU exports, including cars, machinery and manufactured goods are now hit by the full 15% rate. While this prevented Trump's threatened 30% or even 50% duties, it remains a dramatic rise and the highest generalised tariff level imposed on the EU in decades. Major EU concessions on US energy A central element of the deal is the EU's agreement to purchase approximately $750 billion in US energy over the coming years, with a particular focus on liquefied natural gas (LNG) to replace Russian supplies. This marks one of the largest single-sector purchase commitments ever included in a transatlantic trade deal and reflects significant US leverage on Europe's energy security. $600 billion in new EU investments in the US Brussels has agreed to direct around $600 billion in additional investments to the United States in forthcoming years, covering green energy, manufacturing, and military equipment. For context, this matches the scale of the recently announced EU investment pledges for China, underlining the magnitude of this concession. Deal struck during Trump's private tour The agreement was finalised on Trump's private golf estate in Scotland outside EU soil while the UK, no longer a member of the EU, secured a different trade arrangement with the US seen as more favourable. The optics highlight a European desperation to avert more punitive tariffs especially as London was exempted from the harshest terms on steel and aluminium. EU pulls back on retaliation, misses broader show of strength In opting for a settlement, Brussels scrapped or dialled back threatened counter-tariffs, unlike China and Canada both of which have previously matched Trump's measures step for step. Some analysts and European commentators argue the EU missed a chance to assert broader strength instead settling under pressure to avoid economic escalation. Trump's core agenda intact: Steel and aluminium tariffs remain unchanged Despite EU negotiating efforts, the deal leaves in place Trump's 50% tariffs on European steel and aluminium, with only vague promises of a future quota-based relaxation. These metals remain an especially sore point among EU industry lobbyists and the longevity of these trade barriers highlights the limited EU leverage in core strategic sectors. Narrow exemptions: Some sectors spared but automobiles face full impact Certain sectors notably aircraft parts, select chemicals and some agri-products won zero-tariff exemption status. However, automobiles, representing a major chunk of EU exports to the US, fall under the full 15% tariff, a significant new cost for German, French and Italian carmakers already grappling with global market headwinds. While European leaders hailed the agreement as 'providing certainty' and averting a full-scale trade war, many in Europe see it as a lopsided settlement extracted at a moment of vulnerability. The tariff levels, energy purchase commitments, and investment pledges all signify a substantial shift in the transatlantic economic balance, one that, at least for now, appears to favour the US and President Trump's tough bargaining tactics. STORY CONTINUES BELOW THIS AD
Time of India
26 minutes ago
- Time of India
Lavrov Tears Into Europeans For Making Russia ‘World's Villain'; Calls US-EU Trade Deal Big Blow
Russian Foreign Minister Sergey Lavrov sounded an alarm that the deal between the U.S. and EU will inevitably lead to the collapse of European industry. At the Youth Forum 'Territory of Meanings,' Lavrov cautioned: 'American energy resources will be significantly more expensive than Russian ones… this will lead to further deindustrialization of Europe… and the outflow of investments.' He decried the pact as a 'heavy blow'—a strategic shift that may gut Europe's competitive edge while funnelling capital across the Atlantic. Watch. Read More
